INTERVIEWS

Beth Davidson, DNP, ACNP, CHFN, CCRN, a nurse practitioner who specializes in heart failure management in Nashville, TN, and heart failure patient Michele N, discuss the problem of heart failure, providing insight into the impact on African Americans specifically,  the symptoms, and managing the condition.

PolarityTE’s Denver Lough, MD, PhD, discusses the company’s new approach to treating burns with SkinTE  (“autologous” tissue – meaning it comes from the patient being treated, significantly decreasing the chance for rejection by the immune system), the need for additional treatments in this area and case studies to highlight the efficacy of SkinTE.

Dr. William A. Haseltine, scientist, businessman, an expert in biotechnology and healthcare system development, discusses his upcoming book, “WORLD CLASS: A Story of Adversity, Transformation, and Success at NYU Langone Health (Fast Company Press; Feb. 12, 2019).  This book highlights the remarkable turnaround and success of NYU Langone Health.

Dr. Michael Ison from the Feinberg School of Medicine at Northwestern University discusses the current flu season as well as the latest information in flu prevention and treatment options, including the new drug Xofluza (Baloxavir Marboxil) by Genentech.

Dr. Jonathan Sorof, M.D., Senior Vice President, Medical and Regulatory Affairs at Global Blood Therapeutics (GBT),  discusses the disparities in care that people with sickle cell disease (SCD) live with and what can be done to help change that.

Dr. Joan Mannick, Co-Founder, Chief Medical Officer of resTORbio, a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases, discusses their lead program that is selectively targeting TORC1, an evolutionarily conserved pathway that contributes to the decline in function of multiple organ systems, including the immune, cardiovascular and central nervous systems.

Dr. Harold Minkowitz discusses a potential breakthrough in non-opioid post-surgery pain management called HTX-011.

A new study showed that by combining HTX-011 with over-the-counter pain medications, such as Acetaminophen and Ibuprofen, 90% of patients do not require any opioids to manage their post-operative pain for 72 hours after surgery or even needed a discharge prescription for opioids. Above that, 81% of the patients involved in the said study remained completely opioid-free up to 8 days after surgery.

Listen to this podcast episode to get more details.

Dr. Daniel Vorobiof, a renowned medical oncologist with more than 40 years of experience, discusses top tips for caregivers of cancer patients, the role of social media and mobile apps in providing support, and how clinical trial matching works.

Dr. Jeffrey Hoffmeister, MD, VP, Medical Director at iCAD, a global leader in medical technology providing innovative cancer detection and therapy solutions, discusses the role of 3D mammography on radiologist burnout and what steps practices can take to address it.

Returning guest Dr. N. Lawrence Edwards, Chairman, and CEO of The Gout & Uric Acid Education Society discusses the newly formed International Advisory Council (IAC) – a group of eight internationally and domestically acclaimed medical professionals who have shown an interest and expertise in gout care. IAC members collaborate on new ideas and raise awareness of gouty arthritis – with the goal of improving the overall quality of care and minimizing the burden of gout through educational resources.